Biotech SPAC Frazier Lifesciences filed to raise up to $100 million in an IPO.
The sponsor plans to buy $10 million of units in the offering, and purchase another $25 million in a private placement at the time of any acquisition.
Frazier plans to list on the Nasdaq under FLACU. Read more.
